Results 241 to 250 of about 29,657 (272)
Some of the next articles are maybe not open access.

Incidence of infections caused by carbapenem-resistant Acinetobacter baumannii

American Journal of Infection Control, 2019
Carbapenem-resistant Acinetobacter baumannii (CR-Ab) has become a worrying health care problem, mainly in developing countries, such as Brazil. The objective was to investigate the prevalence and prognostic factors for CR-Ab infections at a Brazilian university hospital and examine the impact of inappropriate antimicrobial therapy on patient outcome.A ...
Iara Rossi   +11 more
openaire   +2 more sources

Worldwide Prevalence of Carbapenem Resistance in Acinetobacter baumannii

Infectious Diseases in Clinical Practice, 2023
IntroductionAcinetobacter baumanniiis an opportunistic pathogen that can cause hospital-acquired infections. Indiscriminate use of antibiotics has led to a significant increase in the incidence of acquired drug resistance among clinical isolates ofA. baumannii. This study aims to assess the resistance to carbapenems betweenA. baumanniiclinical isolates
Arian Tavasol   +8 more
openaire   +1 more source

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Italy.

Annali di igiene : medicina preventiva e di comunita, 2020
Our data reinforces the need to monitor the molecular epidemiology of CR A. baumannii and its associated antimicrobial resistance genes at national level.Carbapenem-resistant (CR) Acinetobacter baumannii has been increasingly recognized as a major cause of health care-associated infections in critically ill patients and hospital outbreaks.CR A ...
Zarrilli R.   +4 more
openaire   +3 more sources

Antimicrobial peptide DvAMP combats carbapenem-resistant Acinetobacter baumannii infection

International Journal of Antimicrobial Agents
Carbapenem-resistant Acinetobacter baumannii (CRAB), an important opportunistic pathogen, is a major cause of healthcare-associated infections. The polymyxins (colistin and polymyxin B) are the last line of defense in the treatment of CRAB infections, and there is an urgent need to develop novel alternative therapeutic strategies.
Longbing Yang   +8 more
openaire   +2 more sources

Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients

Transplantation Proceedings, 2018
Acinetobacter baumannii has become an increasingly important nosocomial pathogen. Carbapenem is the preferred drug of choice for treatment of multidrug-resistant gram-negative bacilli, but carbapenem-resistant A baumannii (CRAB) has now emerged. The aim of this study was to determine the incidence, outcomes, and risk factors for CRAB bacteremia in ...
Y J, Kim   +7 more
openaire   +2 more sources

[Mechanism of carbapenems resistance in Acinetobacter baumannii].

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2004
To investigate the mechanism of carbapenems resistance in Acinetobacter baumannii.WHONET-5 software was used to analyze the trend of carbapenem resistance in Acinetobacter baumannii collected from 1999 to 2001 at Peking Union Medical College Hospital. Analytical isoelectric focusing was used to measure the pI of the beta-lactamase.
Hui, Wang   +5 more
openaire   +1 more source

Nursing Home as a Reservoir of Carbapenem-Resistant Acinetobacter baumannii

Microbial Drug Resistance, 2015
Acinetobacter baumannii is an increasingly common pathogen in healthcare settings globally. It is frequently resistant to multiple antimicrobial agents and there are recent reports on strains that are pandrug resistant. The aim of the study was to characterize the mechanisms of carbapenem resistance of
Bedenić, Branka   +7 more
openaire   +3 more sources

Carbapenem-resistant Acinetobacter baumannii in Military Burn Centre

Burns, 2020
Jean-Vivien, Schaal   +4 more
openaire   +2 more sources

Carbapenem-resistant Acinetobacter baumannii Bacteremia in Neonates

Pediatric Infectious Disease Journal, 2013
Narongsak, Nakwan   +1 more
openaire   +2 more sources

Carbapenem resistance in Acinetobacter baumannii isolates from children

2012
Carbapenems have a potent activity against Acinetobacter spp and are often used as last resort for the treatment of infections due to multiresis tant Acinetobacter baumannii isolates. However, Acinetobacters may develop resistance to carbapenems through various combined mechanisms including decreased permeability, altered penicillin binding proteins ...
Bošnjak, Zrinka   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy